Table I.
N (%) | |
---|---|
Age (median, range), years | 70 (44–90) |
Gender | |
Male | 10 (31%) |
Female | 22 (68%) |
ECOG performance status | |
0 | 5 (16%) |
1 | 21 (66%) |
2 | 4 (13%) |
3 | 2 (6%) |
Reason for neoadjuvant therapy | |
Unresectable | 10 (31%) |
Borderline resectable | 16 (50%) |
Resectable but comorbidities | 6 (19%) |
Requiring biliary stent | |
Yes | 21 (66%) |
No | 11 (34%) |